跳至主要内容
临床试验/JPRN-UMIN000048182
JPRN-UMIN000048182尚未招募未知

Effects of Nalmefene on Reduction of Drinking Alcohol and Improvement of Liver Function/Quality of Life in Patients with Alcoholic Liver Disease Treated mainly by Hepatologists - Effects of Nalmefene on Reduction of Drinking Alcohol and Improvement of Liver Function/Quality of Life in Patients with Alcoholic Liver Disease Treated mainly by Hepatologists

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with a history of hypersensitivity to the nalmefene component. Patients receiving opioids (analgesics, anesthetics) or within 1 week of discontinuation of opioid therapy Patients with acute symptoms of opioid dependence or withdrawal Patients who wish to be excluded from the study, Patients who cannot provide written consent Patients experiencing withdrawal symptoms, depressive symptoms or suicide attempts. Patients deemed inappropriate by the attending physician or principal/assistant investigator

研究者

发起方
Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine

相似试验